权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis

大肿瘤诱导前列腺癌进展和转移的分子机制

基本信息

批准号：
10237240
负责人：
Dolores Di Vizio
金额：
$ 48.47万
依托单位：
CEDARS-SINAI MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-01 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10237240
关键词：
Animal Model Animals Bar Codes Biological Assay Biological Process Blood Blood Circulation Bone Marrow COL1A2 gene Caliber Cancer Cell Growth Cancer Patient Castration Cell model Cells Chick Clinical Collaborations Cre-LoxP Data Disease Disease Progression Endothelium Fibroblasts Foundations Gene Deletion Genes Genetic Transcription Gleason Grade for Prostate Cancer Goals Growth Heterogeneity Human Image In Vitro Indolent Intervention Knock-out Laboratories Malignant - descriptor Malignant Neoplasms Malignant neoplasm of prostate Mediating Mediator of activation protein Membrane Metastatic Neoplasm to the Bone Metastatic Prostate Cancer Metastatic to Methods Modeling Molecular Morphogenesis Neoplasm Metastasis Nonmetastatic Oncogenic Oncology Pathway interactions Patient-Focused Outcomes Patients Phenotype Plasma Play Population Positioning Attribute Process Prostate Reporter Resistance Role SPI1 gene Signal Transduction Site Solid Specimen System Testing Tissues Tumor-Derived Vesicle Work androgen sensitive angiogenesis base cancer cell cancer type castration resistant prostate cancer cell stroma clinically significant conditioning exosome experimental study extracellular vesicles genome editing host neoplasm interaction in vivo innovation intercellular communication machine learning method men molecular oncology nano-string novel programs prostate cancer cell prostate cancer metastasis prostate cancer model prostate cancer progression response trafficking tumor tumor growth tumor microenvironment tumor progression uptake

项目摘要

Abstract Prostate cancer (PC) is one of the most frequent tumors in men. Despite recent progress, the disease is still incurable once resistance to castration therapy occurs. Tumor progression is strongly mediated by altered molecular exchanges between cancer cells and the surrounding milieu that originate at the primary sites. However, the mechanisms regulating the response of the stroma to the tumor, which ultimately promote PC progression are still largely unknown. Our laboratory discovered a new type of tumor-derived extracellular vesicle (EV), which are referred to as “large oncosomes” (LO), can harbor more abundant molecular cargo that is distinct and more potently bioactive than that carried by exosomes. The rationale for this proposal derives from our preliminary observations in patients that LO abundance in the circulation correlates with PC progression. Our functional data demonstrate that LO can activate oncogenic signaling in fibroblasts, which respond to LO uptake by activating MYC and SPI1 and by induce a transcriptional program that promotes angiogenesis and stimulates tumor growth. The overarching goal of this project is to determine the functional role of LO in PC progression and metastasis. We hypothesize that LO functionally reprogram normal prostate-associated fibroblasts (NAF) toward a phenotype that is driven by MYC and SPI1 activation. These results strongly suggest that tumor-derived LO might activate intercellular responses that are specific to this subtype of extracellular vesicle. Our hypothesis will be tested with three Specific Aims: Aim 1: To investigate the role of LO-induced fibroblast activation in PC progression. Aim 2: To find evidence that the LO- induced transcriptional program is active in PC patients with clinically significant disease. Aim 3: To test if LO and/or Exo derived from PC patient and PDX specimens promote castration resistance and/or bone metastasis. We will use a combination of complementary in vitro and animal orthotopic models as well as focused approaches involving genome editing, molecular barcodes, and a Cre-Lox reporter in vivo system. Our study will determine if the transcriptional program induced by LO in vitro drives tumor progression and metastasis in vivo. Additionally we will determine if this transcriptional program can also be identified in patient specimens and if it indicative of tumor progression. Finally, our study will provide evidence for LO abilities to induce metastasis of indolent PC cells.

摘要